Arterial stiffness &Sri Lankan chronic kidney disease of unknown origin

Fiona Gifford1,2, Robert Kimmitt1, Chula Herath3

  • 1University/British Heart Foundation Centre of Research Excellence, University of Edinburgh, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.

Scientific Reports
|September 3, 2016
PubMed

Insights

Unexplained chronic kidney disease (CKDu) in Sri Lanka shows less arterial stiffness compared to defined chronic kidney disease (CKD). Further research is needed to determine if this impacts long-term cardiovascular outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a significant risk factor for cardiovascular disease (CVD).
  • Arterial stiffness is a key contributor to CVD risk in CKD patients.
  • A substantial portion of CKD in developing nations, like Sri Lanka, remains unexplained (CKDu).

Purpose of the Study:

  • To compare arterial stiffness in Sri Lankan CKDu patients versus those with defined CKD and healthy controls.
  • To investigate the relationship between CKDu, arterial stiffness, and cardiovascular risk factors.

Main Methods:

  • A cross-sectional study involving 130 participants: 50 with CKDu, 45 with CKD, and 35 controls.
  • Assessment of aortic blood pressure (BP), pulse wave velocity (PWV), and augmentation index (AIx) using the TensioMed™ Arteriograph.
  • Statistical analysis to compare arterial stiffness parameters across the three groups, with and without adjustment for diabetes.

Main Results:

  • Subjects with CKDu and CKD had higher BP than controls, with no significant difference between CKDu and CKD groups.
  • Controls exhibited lower PWV compared to both CKDu and CKD groups.
  • Crucially, CKDu subjects demonstrated significantly lower PWV than CKD subjects, even with equivalent BP and renal dysfunction (8.7 vs. 9.9 m/s).
  • Excluding diabetes further highlighted these differences, with PWV values for controls, CKDu, and CKD being 6.7, 8.7, and 10.4 m/s, respectively (p < 0.001).

Conclusions:

  • Sri Lankan CKDu is associated with reduced arterial stiffness compared to defined CKD.
  • The findings suggest that CKDu may have a different pathophysiological profile regarding vascular health.
  • Long-term cardiovascular morbidity and mortality implications require further investigation in CKDu populations.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
964
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
879
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
553
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
584
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
547
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
580